Steven Cohen's CLYM Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 716,680 shares of Climb Bio, Inc. (CLYM) worth $2.87 M, representing 0.00% of the portfolio. First purchased in 2022-Q1, this short-term holding has been held for 5 quarters.
Based on 13F filings, Steven Cohen has maintained this position in CLYM for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 716,680 shares. Largest reduction occurred in Q4 2024, reducing 590,946 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Climb Bio (CLYM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Climb Bio (CLYM) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +716,680 | New Buy | 716,680 | $4.00 |
| Q4 2024 | -590,946 | Sold Out | 0 | $0.00 |
| Q3 2024 | +590,946 | New Buy | 590,946 | $5.09 |
| Q2 2022 | -142,333 | Sold Out | 0 | $0.00 |
| Q1 2022 | +142,333 | New Buy | 142,333 | $8.39 |
Steven Cohen's Climb Bio Investment FAQs
Steven Cohen first purchased Climb Bio, Inc. (CLYM) in Q1 2022, acquiring 142,333 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Climb Bio, Inc. (CLYM) for 5 quarters since Q1 2022.
Steven Cohen's largest addition to Climb Bio, Inc. (CLYM) was in Q4 2025, adding 716,680 shares worth $2.87 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 716,680 shares of Climb Bio, Inc. (CLYM), valued at approximately $2.87 M.
As of the Q4 2025 filing, Climb Bio, Inc. (CLYM) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Climb Bio, Inc. (CLYM) was 716,680 shares, as reported at the end of Q4 2025.